Demographic, clinical, and treatment characteristics of 1082 five-year survivors of pediatric non-Hodgkin lymphoma (NHL): Childhood Cancer Survivor Study, North America
| . | No. (%) . |
|---|---|
| Sex | |
| Male | 762 (70) |
| Female | 320 (30) |
| Race/ethnicity | |
| White non-Hispanic | 935 (86) |
| Black | 46 (4) |
| Other | 95 (9) |
| Missing | 6 (1) |
| Age at NHL diagnosis, y | |
| ≤4 | 184 (17) |
| 5-9 | 326 (30) |
| 10-14 | 346 (32) |
| 15-21 | 226 (21) |
| Attained age at death or at close of study, years* | |
| <20 | 33 (3) |
| 20-29 | 364 (34) |
| 30-39 | 518 (48) |
| ≥40 | 165 (15) |
| NHL histopathology or cell type† | |
| Burkitt/Burkitt-like (9686.3, 9687.3) | 245 (23) |
| Lymphoblastic (9685.3) and small cell (9670.3, 9672.3) | 244 (23) |
| Diffuse large cell (9680.3-9684.3, 9592.3, 9593.3) | 218 (20) |
| Other histopathology or cell types, specified | 142 (13) |
| Histiocytosis (9720.3, 9723.3) | 52 (5) |
| Follicular and nodular NHL (9690.3-9698.3) | 45 (4) |
| Mixed-cell type (9675.3) | 10 (1) |
| Others (9593.3, 9702.3, 9704.3, 9709.3, 9714.3) | 35 (3) |
| Unspecified cell type (9590.3, 9591.3) | 233 (22) |
| Stage at NHL diagnosis | |
| Not metastatic | 482 (45) |
| Metastatic | 268 (25) |
| Unknown/missing | 332 (31) |
| Site of primary NHL | |
| Lymph nodes | 523 (48) |
| Gastrointestinal tract | 109 (10) |
| Head and neck, including brain | 122 (11) |
| Mediastinum or heart | 81 (7) |
| Bone | 52 (5) |
| Other sites | 140 (13) |
| Unknown | 55 (5) |
| Year of NHL diagnosis | |
| 1970-1973 | 122 (11) |
| 1974-1977 | 211 (20) |
| 1978-1981 | 311 (29) |
| 1982-1986 | 438 (40) |
| Treatment regimens | |
| CT, no RT | 276 (25) |
| RT, no CT | 37 (3) |
| Both RT and CT | 596 (55) |
| Neither RT nor CT | 12 (1) |
| Missing data on either CT or RT | 2 (<1) |
| Missing all treatment data | 159 (15) |
| Bone marrow transplantation | |
| No | 1033 (95) |
| Yes | 29 (3) |
| Unknown/missing | 20 (2) |
| . | No. (%) . |
|---|---|
| Sex | |
| Male | 762 (70) |
| Female | 320 (30) |
| Race/ethnicity | |
| White non-Hispanic | 935 (86) |
| Black | 46 (4) |
| Other | 95 (9) |
| Missing | 6 (1) |
| Age at NHL diagnosis, y | |
| ≤4 | 184 (17) |
| 5-9 | 326 (30) |
| 10-14 | 346 (32) |
| 15-21 | 226 (21) |
| Attained age at death or at close of study, years* | |
| <20 | 33 (3) |
| 20-29 | 364 (34) |
| 30-39 | 518 (48) |
| ≥40 | 165 (15) |
| NHL histopathology or cell type† | |
| Burkitt/Burkitt-like (9686.3, 9687.3) | 245 (23) |
| Lymphoblastic (9685.3) and small cell (9670.3, 9672.3) | 244 (23) |
| Diffuse large cell (9680.3-9684.3, 9592.3, 9593.3) | 218 (20) |
| Other histopathology or cell types, specified | 142 (13) |
| Histiocytosis (9720.3, 9723.3) | 52 (5) |
| Follicular and nodular NHL (9690.3-9698.3) | 45 (4) |
| Mixed-cell type (9675.3) | 10 (1) |
| Others (9593.3, 9702.3, 9704.3, 9709.3, 9714.3) | 35 (3) |
| Unspecified cell type (9590.3, 9591.3) | 233 (22) |
| Stage at NHL diagnosis | |
| Not metastatic | 482 (45) |
| Metastatic | 268 (25) |
| Unknown/missing | 332 (31) |
| Site of primary NHL | |
| Lymph nodes | 523 (48) |
| Gastrointestinal tract | 109 (10) |
| Head and neck, including brain | 122 (11) |
| Mediastinum or heart | 81 (7) |
| Bone | 52 (5) |
| Other sites | 140 (13) |
| Unknown | 55 (5) |
| Year of NHL diagnosis | |
| 1970-1973 | 122 (11) |
| 1974-1977 | 211 (20) |
| 1978-1981 | 311 (29) |
| 1982-1986 | 438 (40) |
| Treatment regimens | |
| CT, no RT | 276 (25) |
| RT, no CT | 37 (3) |
| Both RT and CT | 596 (55) |
| Neither RT nor CT | 12 (1) |
| Missing data on either CT or RT | 2 (<1) |
| Missing all treatment data | 159 (15) |
| Bone marrow transplantation | |
| No | 1033 (95) |
| Yes | 29 (3) |
| Unknown/missing | 20 (2) |